Brief: Pacira Biosciences Advances Pcrx-201 Development Program With Successful Transition To Scalable Commercial Manufacturing Process
27/07/2026 13:02
BRIEF-Pacira Biosciences Advances Pcrx-201 Development Program With Successful Transition To Scalable Commercial Manufacturing Process July 27 (Reuters) - Pacira Biosciences Inc PCRX.O:
PACIRA BIOSCIENCES ADVANCES PCRX-201 DEVELOPMENT PROGRAM WITH SUCCESSFUL TRANSITION TO SCALABLE COMMERCIAL MANUFACTURING PROCESS
PACIRA BIOSCIENCES - PART A ASCEND ENROLLMENT CONCLUDED; TOPLINE DATA EXPECTED BY END OF 2026
Source text: ID:nGNX788BFH
Further company coverage: PCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal